Old Web
English
Sign In
Acemap
>
Paper
>
Brodalumab in psoriatic arthritis (PsA): 24-week results from the phase III AMVISON-1 and -2 trials
Brodalumab in psoriatic arthritis (PsA): 24-week results from the phase III AMVISON-1 and -2 trials
2019
I McInnes
P. Mease
KF Hjuler
K Raymond
P. Helliwell
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]